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The vertebrate globins are a group of hemoproteins with the intrinsic capacity to regulate gaseous
ligands and redox signaling required for cardiovascular biology. This graphical review will provide a
comprehensive synopsis of somatic cardiovascular globins focusing on expression, function and redox
signaling – an emerging area in both physiology and disease.
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Introduction
The globins are a family of small globular proteins that stru-
cturally consist of a conserved “globin fold” and a series of eight
alpha-helical segments (named A-H) [1–3]. Globins evolved from a
common ancestor, four of which reside in vertebrates: hemoglobin
(Hb), myoglobin (Mb), cytoglobin (Cgb) and neuroglobin (Ngb) [4].
Harboring a heme-prosthetic group (Fe-protoporphyrin IX), Hb
and Mb are penta-coordinate, whereas Cgb and Ngb possess a
hexa-coordinate conﬁguration. Globins predominantly operate to
reversibly bind gaseous ligands, such as oxygen (O2) and carbon
dioxide (CO2), to the heme group for storage and transport. This
property permits globins to fulﬁll obligatory aerobic respiratory
needs for tissue function and homeostasis. In addition to their
respiratory function, it has been long known that globins, espe-
cially Hb and Mb, take on other cellular roles such as reduction
and oxidation (redox) reactions with ligands such as nitric
oxide (NO), nitrite (NO2), and hydrogen peroxide (H2O2) [5,6].
These functions are critically important in vascular cells, both of
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hematopoietic and of somatic origin. Recently, somatic cardiovas-
cular globin expression and function has received much attention
for their roles with regard to redox reactions that control reactive
oxygen and nitrogen signaling (Fig. 1).
Within the cardiovascular system, cell-type expression and loca-
lization of each globin is variable. Hb, composed of α and β chains,
was traditionally known for exclusive expression in red blood cells,
although a recent reports have dismissed this perception through the
discovery of Hb α expression in microvascular endothelial cells [7,8].
Mb expression is abundant in cardiomyocytes but is found to a lesser
extent in vascular smooth muscle cells [9,10]. Cgb chieﬂy resides in
cardiomyocytes, advential ﬁbroblasts and vascular smooth muscle
cells [11,12], whereas sympathetic nerves express Ngb [13]. Remark-
ably, globin expression is not homogeneous through the vascular
tree. This is particularly true for Hb and Mb. Hb α expression is
mainly found in resistance arteries and arterioles [7], whereas Mb is
primarily expressed in conduit arteries but absent in small arteries
[7,10] (Fig. 2). The explanation for globin expression inconsistency
throughout the vascular tree remains unknown. These disparities
likely reﬂect speciﬁc transcriptional, post-transcriptional, and trans-
lational events for each globin as it relates to their precise role
(s) within the vascular cell itself.
Hemoglobin, myoglobin, cytoglobin and neuroglobin function in the
cardiovascular system
Hemoglobin
Hemoglobin A is the major form in adult red blood cells and is
encoded by duplicated HBA1 and HBA2 genes and by the HBB gene
(reviewed in [14]). Hb protein is assembled into heterotetramers,
comprised of two α-globin and two β-globin polypeptides, capable
of binding multiple gaseous ligands such as O2, carbon monoxide
(CO), and NO [15]. In the cardiovascular system, red blood cell Hb
is best known to mediate O2 delivery and the removal of CO2 from
peripheral tissues. Hb accomplishes this by cooperatively binding
O2 in the lungs and transporting it to capillaries, where it is
deployed to parenchymal cells and exchanged for CO2 [3,16–18].
Mechanistically, these functions are carried out through the heme
group, which contains an iron atom (Fe) in the reduced state
Fig. 1. Schematic outline of the vertebrate globins in the cardiovascular system highlighting cell-type speciﬁc expression, biochemical functions and phylogenetic features.
Fig. 2. Cell type-speciﬁc expression of hemoglobin, myoglobin, cytoglobin and
neuroglobin along the vascular tree.
M.M. Rahaman, A.C. Straub / Redox Biology 1 (2013) 405–410406
(Fe2þ), where ﬁve of the six coordination sites of the Fe are
occupied, four by the porphyrin ring and one by the proximal
histidine (His) of the surrounding globin polypeptide. The sixth
coordination site is bound reversibly by O2 and CO2. During the
cardio-respiratory cycle, delivery and removal of O2 and CO2
induces no chemical (covalent) or redox change to the heme
Fe group.
Besides oxygen, Hb is well known for its reactivity with NO, a
powerful vasodilator [19,20]. In fact, the ability of oxygen-bound
Hb (oxy-Hb) to scavenge NO was a deﬁning feature that unveiled
NO as endothelium derived relaxing factor [21]. The biochemical
reaction of oxy-Hb and NO has largely been ascribed to the
dioxygenation reaction, which is fast (2.4107 M1s1) and
irreversible, resulting in a two-electron oxidation of NO forming
met-Hb (Hb-Fe3þ) and nitrate (NO3) [22–24]. As a consequence,
oxy-Hb severely limits NO diffusion with a half-life of 0.5 μs.
Although this provides a mechanism to limit NO toxicity, the
reaction creates a physiological paradox, whereby abundant con-
centrations of Hb in red blood cells (10 mM) should reduce NO
bioavailability from endothelium to vascular smooth muscle.
However, in the resistance vasculature – arteries and arterioles
that control blood pressure and ﬂow – recent evidence identiﬁed
that endothelial nitric oxide synthase (eNOS) polarizes and
enriches at the myoendothelial junction, the structural location
where endothelium and smooth muscle juxtapose [25]. This
spatial polarization provides a mechanism that the resistance
arterial vessels use to protect eNOS-derived NO from oxy-Hb in
red blood cells. Despite this anatomical safeguard from red blood
cell Hb, the Hb-NO paradox was further compounded with the
recent identiﬁcation of Hb α expression and enrichment at
myoendothelial junctions [7]. This leads to uncertainty, question-
ing why the resistance arterial endothelium evolved to “sandwich
or encapsulate” eNOS with Hb.
One explanation could be extrapolated from a functional point
of view. Vascular resistance and blood ﬂow are hypersensitive to
arterial radius ﬂuctuations, which can be derived from Poiseulille's
law. Poiseulille's law states that “vessel resistance is directly
proportional to the length of the vessel and the viscosity of blood
and inversely proportional to the radius to the fourth power”. For
example, a 2-fold increase in radius yields a 16-fold decrease in
vascular resistance/blood ﬂow. From an operative point of view,
this commands precise and highly controlled mechanisms for
regulation of vasodilation and vasoconstriction. NO, which is not
directional and diffusion limited, may not offer the precise level of
control required for optimally regulating vascular resistance and
blood ﬂow. In fact, it is well established that the NO pathway plays
a relatively minor role in resistance arterial vasoreactivity. For
example, in mesenteric arteries acetylcholine-induced vasodila-
tion is regulated mainly by endothelial derived hyperpolarizing
factor (EDHF) [26,27]. This concept also holds true for vasocon-
striction. It is known that during contraction, signals originating
from vascular smooth muscle disseminate to endothelium to
activate vasodilatory pathways, including NO signaling [25,28].
Overproduction of NO is known to inhibit the contractile response
[7,25], suggesting that controlled NO diffusion to vascular smooth
muscle is crucial for vascular tone regulation. This positions Hb as
an ideal protein to control NO bioavailability in the microcircula-
tion during agonist-induced activation. This questions why the NO
pathway is active in the microcirculation. Although the classic
agonist-induced NO-stimulated cGMP pathway does not play a
major role in vasodilation and vasoconstriction, NO signaling is
fundamental for regulating other elements of vascular signaling
including basal vascular tone, protein S-nitrosation, anti-coagula-
tion, anti-proliferation and anti-inﬂammatory signaling.
One of the most remarkable functions of Hb α in the resistance
arterial endothelium is its capacity to deactivate NO via the Hb
oxidation state [7]. During agonist-induced stimulation with either
acetylcholine or phenylephrine, it was shown that met-Hb α
permits NO signaling to smooth muscle through a slow, weak
interaction with heme Fe (3.3103 M1 s1), whereas oxy-Hb α
inhibited signaling through the fast, irreversible dioxygenation
reaction (2.4107 M1 s1). It was discovered that met-Hb reduc-
tase or cytochrome B5 reductase 3 (CytB5R3) was critical for the
redox cycling frommet-Hb α to oxy-Hb α. This paradigm highlights
an emerging, yet critically important role for Hb redox state,
whereby NO signaling can be switched “on-or-off” (Fig. 3). This
evidence may provide a plausible explanation for understanding
the Hb-NO paradox in the physiology of blood pressure and ﬂow
control. Intriguingly, this paradigm of Hb-NO regulation in somatic
cells may go beyond arterial endothelial cells. In fact, many other
cell types including Type II alveolar epithelial cells [29–31], renal
mesangial cells [32], hepatocytes [33], macrophages [34], neurons
[35–39] and endometrial cells [40] express Hb (Fig. 4).
Historically, Hb has been considered to solely react with NO in
a manner to suppress the NO signal through the dioxygenation
reaction as described above. This reaction requires O2 bound Hb.
Amazingly, Hb has the capacity to switch from a NO scavenger to a
NO synthase under low O2 levels [41]. In doing so, hypoxic
conditions facilitate Hb-to reduce nitrite, resulting in NO
formation. Currently, it is known that red blood cell hemoglobin
is a nitrite reductase but it is unknown whether Hb α serves as a
nitrite reductase in endothelial cells. Another function for Hb is its
capability to generate S-nitrosothiols, which are important
signaling molecules for post-translational modiﬁcation of proteins.
Hb can synthesize these molecules via reductive nitrosylation [42–
44] or through a nitrite anhydrase reaction [45–47]. Collectively,
NO and its interaction with Hb assimilates a relationship that is
Fig. 3. Mechanism of Hb α-regulated NO signaling in endothelial cells. Hb α is
expressed in small artery and arteriolar endothelial cells and enriched at the
myoendothelial junction (lower left hand corner). Nitric oxide, released from eNOS,
reacts with oxy-Hb αFe
2þ
resulting in NO scavenging (dioxygenation reaction) or
reacts with Hb αFe
3þ
resulting in a slow and weak binding NO allowing for
diffusion. The cycling of Hb αFe
3þ
to Hb αFe
2þ
is controlled by a CytB5 and CytB5R3
dependent mechanism.
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bound by O2, whereby the biochemical and signaling nature of NO
is highly controlled by O2 tension.
Hemoglobin also has peroxidative properties when it reacts
with oxidants such as hydrogen peroxide (reviewed in [48]).
Excessive intravascular Hb exposure can result in profound tissue
damage by causing lipid peroxide protein modiﬁcations and by
scavenging NO [49,50]. However, Hb can also have protective
effects, suggesting that the biological consequences of Hb in a
H2O2-rich environment likely entails a balance of anti-oxidant
function and protection or excessive reactive oxygen species and
oxidative stress [51]. In fact, recent work demonstrated that Hb
expression in renal mesangial cells and hepatocytes attenuate
oxidative stress. Thus it is possible that Hb, particularly in
endothelial cells, may have other functions besides control of NO
signaling as well as possible roles in reactive oxygen signaling and
stress responses.
Myoglobin
Mb, a monomeric heme-bound globin, is well known for its
ability to store oxygen within cells [9,52]. Like Hb, Mb has the
capacity to bind small molecule ligands such as O2, NO and CO at
its sixth coordinate position. In the cardiovascular system, myo-
globin protein is abundantly expressed in the cytoplasm of
cardiomyocytes and to a much lesser extent vascular smooth
muscle [9,53]. Functionally, Mb can fulﬁll many roles within
vascular cells. Initial work found that Mb can reversibly bind O2
and showed a hyperbolic O2 dissociation curve. In cardiac muscle,
Mb has a high afﬁnity for O2 with a P50 of 1 Torr, with the cytosolic
pool of Mb maintained between 35% and 50% oxygen saturation
[9]. Based on this biochemical evidence, particularly in working
muscle such as cardiomyocytes, Mb is poised as an ideal candidate
for short-term O2 storage and delivery in times of hypoxic
challenge. Currently, this function for Mb is the most accepted.
To a lesser extent, Mb may mediate facilitated oxygen diffusion
in vivo [6].
Similarly to Hb, Mb has NO dioxygenation activity with a
reaction rate of 5107 M1 s1 [54,55]. It is thought that the
dioxygenase function of Mb prevents NO mediated inhibition of
mitochondrial respiration, which would facilitate a higher rate of
oxidative phosphorylation [56]. Perhaps one of the most impor-
tant functions of myoglobin is its ability to serve as a nitrite
reductase [57]. Nitrite is found basally at approximately 1–10 μM
in the heart and can be reduced to bioactive NO [58]. Under low
oxygen conditions, it has been demonstrated that myoglobin
inhibits mitochondrial respiration in cardiomyocytes below the
P50 of myoglobin [57]. Together, these studies highlight the
important role of myoglobin regulated NO signaling.
It is critical to point out that Mb also functions as an intracel-
lular catalyst. In vitro studies have demonstrated that Fe2þ and
Fe3þ Mb react with reactive oxygen species particularly H2O2, in a
similar fashion to Hb [59]. The reaction with H2O2 leads to Fe4þ–
Mb formation, a powerful oxidant that can oxidize proteins and
lipids. Fe4þ–Mb can react with protein radicals forming cross-
linked species as well as initiating lipid peroxidation. This oxida-
tive chemistry may be a detrimental pathway that initiates and
exacerbates many cardiovascular related diseases.
Cytoglobin
Cytb, a new member of the globin family displays comparable
tertiary structure and the globin fold analogous to Hb and Mb,
however, it resides in a dimeric quaternary state [60]. Cytb protein
is expressed in varying tissues types [61] compared to the speciﬁc
expression patterns of Hb and Mb. In the vasculature, Cytb is
abundantly found in vascular smooth muscle, adventital ﬁbro-
blasts and cardiomyocytes, while endothelial cells express little
protein [11,12]. Functionally, Cytb is localized to the cytosol,
implying that it likely plays a role in O2 storage similar to
Mb [12]. The P50 for O2 is comparable to Mb (1 Torr), however,
the binding of O2 is cooperative [62]. This indicates that Cytb may
permit greater O2 loading and unloading with a narrow range of
O2 tensions, making it an ideal protein for tissue O2 storage and
deployment during hypoxic challenge. During hypoxia, Cytb mRNA
is abundantly expressed in the adult heart, translating into a
marked increase of Cygb protein within the hypoxia-induced
hypertrophic myocardium. The regulation of Cygb transcription
was reported to be calcineurin-dependent suggesting that Cygb
may have a functional role in calcium-dependent events accom-
panying cardiac remodeling [11].
Cygb consumes NO through the dioxygenase pathway, which
regulates cell proliferation and respiration [12,62–64]. Recent
work demonstrated that O2-dependent NO metabolism can be
controlled by rapid reduction of Cytb by the cellular reductant
ascorbate [65]. Expression of Cytb, predominantly in vascular
smooth muscle, may likely provide another layer of NO control
for vascular tone regulation, especially in the microcirculation.
Similar to Hb, cytoglobin can also serve as a nitrite reductase,
generating NO and activating soluble guanylyl cyclase in vascular
smooth cells [66]. In addition Cytb can also serve as a S-nitrosthiol
synthase [67]. Future studies using Cytb knockout mice will
provide valuable insight into other potential roles for Cytb in
cardiovascular biology [68].
Neuroglobin
The most distantly related globin found in the human genome
is Ngb, encoded by NGB [69]. Ngb is related to the invertebrate
Fig. 4. Known somatic cell types that express hemoglobin, the identiﬁed chains, and functions.
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nerve globins, indicating that an ancestral gene was present before
the divergence of vertebrates and invertebrates more than 800
million years ago [70]. Ngb mRNA is abundant in mammalian
nerve cells of the central and peripheral nervous system [13].
In the cardiovascular system, sympathetic nerves express Ngb,
however, no expression was found in systemic endothelium or
vascular smooth muscle [7,13]. Hypoxia has been shown to increase
Ngb expression [71]. The O2 afﬁnity of Ngb is sensitive to changes in
pH and temperature, which indicates that Ngb may act to facilitate
O2 supply [62]. Ngb may also function as a scavenger for reactive
oxygen and nitrogen species functioning in a neuroprotective role
after ischemia and reperfusion in the brain [72]. However, EPR and
kinetic studies revealed that the binding of NO to Ngb-Fe2þ is
relatively low compared to penta-coordinate Hb and Mb [72]. Ngb
can also serve as a nitrite reductase, in which redox sensitive surface
thiols are critical for the binding of nitrite and the production of NO
[73]. These thiols are likely linked to the redox state of the cell, which
may control Ngb function [64]. The role of Ngb in perivascular
sympathetic nerves remains unknown, however, it may contribute
to catecholamine release or neuronal nitric oxide synthase-derived
NO regulation.
Future directions
While the ﬁeld of cardiovascular globin biology is evolving,
several challenges remain. First, the transcriptional, post-
transcriptional and protein–protein interactions that regulate each
globin in somatic vascular cells are poorly understood and will
require more study. Second, further work is necessary to under-
stand how the redox state of each globin is controlled in somatic
vascular cells. Lastly, additional effort will be needed to dissect the
individual and communal roles of globins and how they function
in both cardiovascular physiology and disease.
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